Department of Obstetrics and Gynaecology

Cell-In-Cell Structures in Early Breast Cancer Are Prognostically Valuable (2023) Bauer M, Hildebrand L, Rosahl MC, Erber R, Schnellhardt S, Büttner-Herold M, Putz F, et al. Journal article Age-related Differences in Immune Reactions to SARS-CoV-2 Spike and Nucleocapsid Antigens (2023) Morhart P, Kehl S, Schuh W, Hermes K, Meltendorf S, Neubert A, Schneider M, et al. Journal article Characterization of the impact of immune checkpoint inhibitors on platelet activation and aggregation (2023) Schlüter J, Cunningham S, Zimmermann R, Achenbach S, Kramer R, Erdmann M, Beckmann M, et al. Journal article Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery (2023) Phung MT, Webb PM, DeFazio A, Fereday S, Lee AW, Bowtell DD, Fasching P, et al. Journal article Learning laparoscopic hysterectomy: analysis of different surgeons' individual learning curves (2022) Schutzenduebel M, Boosz A, Baev E, Häberle L, Muller A Journal article Sarcoma of the UterusGuideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021) (2022) Denschlag D, Ackermann S, Battista MJ, Cremer W, Egerer G, Fehr M, Follmann M, et al. Journal article Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients (Breast Cancer Research, (2022), 24, 1, (69), 10.1186/s13058-022-01567-3) (2022) Giardiello D, Hooning MJ, Hauptmann M, Keeman R, Heemskerk-Gerritsen BA, Becher H, Blomqvist C, et al. Journal article, Erratum Q-TWiST analysis of pembrolizumab combined with chemotherapy as first-line treatment of metastatic triple-negative breast cancer that expresses PD-L1 (2022) Huang M, O'Shaughnessy J, Haiderali A, Pan W, Hu P, Chaudhuri M, Le Bailly De Tilleghem C, et al. Journal article A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE) (2022) Schmidt M, Lübbe K, Decker T, Thill M, Bauer L, Müller V, Link T, et al. Journal article PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients (2022) Giardiello D, Hooning MJ, Hauptmann M, Keeman R, Heemskerk-Gerritsen BAM, Becher H, Blomqvist C, et al. Journal article